Patents by Inventor Tore Seternes
Tore Seternes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250144025Abstract: This invention provides an oral pharmaceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion containing a drug of abuse.Type: ApplicationFiled: June 7, 2024Publication date: May 8, 2025Applicant: VITUX GROUP ASInventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes, Magnus N. Hattrem
-
Patent number: 10966926Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.Type: GrantFiled: October 19, 2011Date of Patent: April 6, 2021Assignee: VITUX GROUP ASInventors: Kurt Ingar Draget, Steinar Johan Engelsen, Tore Seternes, Magnus Hattrem, Ingvild Johanne Haug
-
Patent number: 10668013Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.Type: GrantFiled: June 30, 2017Date of Patent: June 2, 2020Assignee: VITUX GROUP ASInventors: Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug
-
Publication number: 20190269677Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.Type: ApplicationFiled: May 20, 2019Publication date: September 5, 2019Applicant: VITUX GROUP ASInventors: Kurt Ingar DRAGET, Ingvild Johanne HAUG, Steinar Johan ENGELSEN, Tore SETERNES
-
Publication number: 20170296467Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.Type: ApplicationFiled: June 30, 2017Publication date: October 19, 2017Applicant: VITUX GROUP ASInventors: Tore SETERNES, Kurt Ingar DRAGET, Ingvild Johanne HAUG
-
Patent number: 9724296Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.Type: GrantFiled: October 15, 2014Date of Patent: August 8, 2017Assignee: VITUX GROUP ASInventors: Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug
-
Publication number: 20170105992Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.Type: ApplicationFiled: December 27, 2016Publication date: April 20, 2017Applicant: AYANDA GROUP ASInventors: Kurt Ingar DRAGET, Ingvild Johanne HAUG, Steinar Johan ENGELSEN, Tore SETERNES
-
Publication number: 20150037438Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.Type: ApplicationFiled: October 15, 2014Publication date: February 5, 2015Inventors: Tore SETERNES, Kurt Ingar Draget, Ingvild Johanne Haug
-
Publication number: 20140163108Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.Type: ApplicationFiled: October 19, 2011Publication date: June 12, 2014Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Steinar Johan Engelsen, Tore Seternes, Magnus Hattrem, Ingvild Johanne Haug
-
Publication number: 20140005179Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.Type: ApplicationFiled: April 11, 2011Publication date: January 2, 2014Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Ingvild Haug, Magnus N. Hattrem, Tore Seternes, Steinar Johan Engelsen
-
Publication number: 20130273152Abstract: This invention provides an oral pharmaceutical composition comprising a physiologically tolerable shell containing a drug of abuse within an oil comprising physiologically tolerable unsaturated fatty acids.Type: ApplicationFiled: April 11, 2011Publication date: October 17, 2013Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes
-
Publication number: 20130273025Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.Type: ApplicationFiled: April 11, 2011Publication date: October 17, 2013Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes
-
Publication number: 20130274280Abstract: This invention provides an oral pharmaceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion containing a drug of abuse.Type: ApplicationFiled: April 11, 2011Publication date: October 17, 2013Applicant: AYANDA GROUP ASInventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes, Magnus N. Hattrem
-
Publication number: 20110268771Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.Type: ApplicationFiled: October 8, 2009Publication date: November 3, 2011Applicant: PROBIO ASAInventors: Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug
-
Publication number: 20110268770Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a statin within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion, one or both of the oil phase and the water phase whereof comprises a physiologically tolerable omega-3 acid ester.Type: ApplicationFiled: October 8, 2009Publication date: November 3, 2011Applicant: PROBIO ASAInventors: Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug